Author | Hetty Carraway | OncLive

Author | Hetty Carraway

Articles

Dr. Carraway on Aza-Nucleoside Combinations in MDS

September 18, 2015

Video

Hetty Carraway, MD, Hematology and Oncology, Cleveland Clinic, discusses combination epigenetic therapies including aza-nucleosides and histone deacetylase inhibitors, as well as immunomodulatory therapies, such as lenalidomide for the treatment of myelodysplastic syndromes (MDS).

x